Epigenetic Drug Discovery: Targeting DNA Methyltransferases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kornberg, 1974, Chromatin Structure: A Repeating Unit of Histones and DNA, Science, 184, 868, 10.1126/science.184.4139.868
Klug, 1980, A Low Resolution Structure for the Histone Core of the Nucleosome, Nature, 287, 509, 10.1038/287509a0
Arents, 1991, The Nucleosomal Core Histone Octamer at 3.1 A Resolution: A Tripartite Protein Assembly and a Left-Handed Superhelix, Proc. Natl. Acad. Sci. U. S. A., 88, 10148, 10.1073/pnas.88.22.10148
Luger, 1997, Crystal Structure of the Nucleosome Core Particle at 2.8 A Resolution, Nature, 389, 251, 10.1038/38444
Herman, 2003, Gene Silencing in Cancer in Association with Promoter Hypermethylation, N. Engl. J. Med., 349, 10.1056/NEJMra023075
Kirmizis, 2004, Silencing of Human Polycomb Target Genes Is Associated with Methylation of Histone H3 Lys 27, Genes Dev., 18, 1592, 10.1101/gad.1200204
Szyf, 2010, A Dynamic Methylome: Implications of Non-CG Methylation/Demethylation, Cell Cycle, 9, 3846, 10.4161/cc.9.19.13563
Upadhyay, 2011, Dynamics of Histone Lysine Methylation: Structures of Methyl Writers and Erasers, Prog. Drug Res., 67, 107
Taberlay, 2011, DNA Methylation and Cancer, Prog. Drug Res., 67, 1
Miranda, 2007, DNA Methylation: The Nuts and Bolts of Repression, J. Cell Physiol., 213, 384, 10.1002/jcp.21224
Baylin, 2006, Epigenetic Gene Silencing in Cancer: A Mechanism for Early Oncogenic Pathway Addiction?, Nat. Rev. Cancer, 6, 107, 10.1038/nrc1799
Pedrali-Noy, 1986, Mammalian DNA Methyltransferases Prefer Poly(dI-dC) as Substrate, J. Biol. Chem., 261, 7600, 10.1016/S0021-9258(19)57438-5
Kim, 2002, Co-operation and Communication between the Human Maintenance and De Novo DNA (cytosine-5) Methyltransferases, EMBO J., 21, 4183, 10.1093/emboj/cdf401
Ross, 2010, Recombinant Mammalian DNA Methyltransferase Activity on Model Transcriptional Gene Silencing Short RNA-DNA Heteroduplex Substrates, Biochem. J., 432, 323, 10.1042/BJ20100579
Chuang, 1997, Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21WAF1, Science, 277, 1996, 10.1126/science.277.5334.1996
Bostick, 2007, UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells, Science, 317, 1760, 10.1126/science.1147939
Spada, 2007, DNMT1 but Not Its Interaction with the Replication Machinery Is Required for Maintenance of DNA Methylation in Human Cells, J. Cell Biol., 176, 565, 10.1083/jcb.200610062
Li, 1992, Targeted Mutation of the DNA Methyltransferase Gene Results in Embryonic Lethality, Cell, 69, 915, 10.1016/0092-8674(92)90611-F
Muto, 2002, Targeted Disruption of Np95 Gene Renders Murine Embryonic Stem Cells Hypersensitive to DNA Damaging Agents and DNA Replication Blocks, J. Biol. Chem., 277, 34549, 10.1074/jbc.M205189200
Lei, 1996, De Novo DNA Cytosine Methyltransferase Activities in Mouse Embryonic Stem Cells, Development, 122, 3195, 10.1242/dev.122.10.3195
Jackson-Grusby, 2001, Loss of Genomic Methylation Causes p53-Dependent Apoptosis and Epigenetic Deregulation, Nat. Genet., 27, 31, 10.1038/83730
Sharif, 2007, The SRA Protein Np95 Mediates Epigenetic Inheritance by Recruiting Dnmt1 to Methylated DNA, Nature, 450, 908, 10.1038/nature06397
Egger, 2006, Identification of DNMT1 (DNA Methyltransferase 1) Hypomorphs in Somatic Knockouts Suggests an Essential Role for DNMT1 in Cell Survival, Proc. Natl. Acad. Sci. U. S. A., 103, 14080, 10.1073/pnas.0604602103
Chen, 2007, Complete Inactivation of DNMT1 Leads to Mitotic Catastrophe in Human Cancer Cells, Nat. Genet., 39, 391, 10.1038/ng1982
Goll, 2006, Methylation of tRNAAsp by the DNA Methyltransferase Homolog Dnmt2, Science, 311, 395, 10.1126/science.1120976
Okano, 1999, DNA methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development, Cell, 99, 247, 10.1016/S0092-8674(00)81656-6
Gowher, 2002, Molecular Enzymology of the Catalytic Domains of the Dnmt3a and Dnmt3b DNA Methyltransferases, J. Biol. Chem., 277, 20409, 10.1074/jbc.M202148200
Goll, 2005, Eukaryotic Cytosine Methyltransferases, Annu. Rev. Biochem., 74, 481, 10.1146/annurev.biochem.74.010904.153721
Rhee, 2002, DNMT1 and DNMT3b Cooperate to Silence Genes in Human Cancer Cells, Nature, 416, 10.1038/416552a
Liang, 2002, Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements, Mol. Cell Biol., 22, 480, 10.1128/MCB.22.2.480-491.2002
Chen, 2003, Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b, Mol. Cell Biol., 23, 5594, 10.1128/MCB.23.16.5594-5605.2003
Kaneda, 2004, Essential Role for De Novo DNA Methyltransferase Dnmt3a in Paternal and Maternal Imprinting, Nature, 429, 900, 10.1038/nature02633
Bourc’his, 2001, Dnmt3L and the Establishment of Maternal Genomic Imprints, Science, 294, 2536, 10.1126/science.1065848
Bourc’his, 2004, Meiotic Catastrophe and Retrotransposon Reactivation in Male Germ Cells Lacking Dnmt3L, Nature, 431, 96, 10.1038/nature02886
Hata, 2002, Dnmt3L Cooperates with the Dnmt3 Family of De Novo DNA Methyltransferases to Establish Maternal Imprints in Mice, Development, 129, 1983, 10.1242/dev.129.8.1983
Gowher, 2005, Mechanism of Stimulation of Catalytic Activity of Dnmt3A and Dnmt3B DNA-(Cytosine-C5)-Methyltransferases by Dnmt3L, J. Biol. Chem., 280, 13341, 10.1074/jbc.M413412200
Jia, 2007, Structure of Dnmt3a Bound to Dnmt3L Suggests a Model for De Novo DNA Methylation, Nature, 449, 248, 10.1038/nature06146
Klein, 2011, Mutations in DNMT1 Cause Hereditary Sensory Neuropathy with Dementia and Hearing Loss, Nat Genet, 43, 595, 10.1038/ng.830
Margot, 2000, Structure and Function of the Mouse DNA Methyltransferase Gene: Dnmt1 Shows a Tripartite Structure, J. Mol. Biol., 297, 293, 10.1006/jmbi.2000.3588
Xu, 1999, Chromosome Instability and Immunodeficiency Syndrome Caused by Mutations in a DNA Methyltransferase Gene, Nature, 402, 187, 10.1038/46052
Ehrlich, 2008, ICF, an Immunodeficiency Syndrome: DNA Methyltransferase 3B Involvement, Chromosome Anomalies, and Gene Dysregulation, Autoimmunity, 41, 253, 10.1080/08916930802024202
Narayan, 2000, Hypersensitivity to Radiation-Induced Non-Apoptotic and Apoptotic Death in Cell Lines from Patients with the ICF Chromosome Instability Syndrome, Mutat. Res., 456, 1, 10.1016/S0027-5107(00)00103-2
Walter, 2011, Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes, Leukemia, 25, 1153, 10.1038/leu.2011.44
Ley, 2010, DNMT3A Mutations in Acute Myeloid Leukemia, N. Engl. J. Med., 363, 2424, 10.1056/NEJMoa1005143
Yan, 2011, Exome Sequencing Identifies Somatic Mutations of DNA Methyltransferase Gene DNMT3A in Acute Monocytic Leukemia, Nat. Genet., 43, 309, 10.1038/ng.788
Eklund, 2007, The Role of HOX Genes in Malignant Myeloid Disease, Curr. Opin. Hematol., 14, 85, 10.1097/MOH.0b013e32801684b6
Shah, 2010, The Hox Genes and Their Roles in Oncogenesis, Nat. Rev. Cancer, 10, 361, 10.1038/nrc2826
Feinberg, 1983, Hypomethylation Distinguishes Genes of Some Human Cancers from Their Normal Counterparts, Nature, 301, 89, 10.1038/301089a0
Riggs, 1983, 5-Methylcytosine, Gene Regulation, and Cancer, Adv. Cancer Res., 40, 1, 10.1016/S0065-230X(08)60678-8
Arnold, 2004, APC Promoter Hypermethylation Contributes to the Loss of APC Expression in Colorectal Cancers with Allelic Loss on 5q, Cancer Biol. Ther., 3, 960, 10.4161/cbt.3.10.1113
Chen, 2005, Molecular Analysis of APC Promoter Methylation and Protein Expression in Colorectal Cancer Metastasis, Carcinogenesis, 26, 37, 10.1093/carcin/bgh280
Virmani, 2001, Aberrant Methylation of the Adenomatous Polyposis Coli (APC) Gene Promoter 1A in Breast and Lung Carcinomas, Clin. Cancer Res., 7, 1998
Esteller, 2001, A Gene Hypermethylation Profile of Human Cancer, Cancer Res., 61, 3225
Dobrovic, 1997, Methylation of the BRCA1 Gene in Sporadic Breast Cancer, Cancer Res., 57, 3347
Esteller, 2000, Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors, J. Natl. Cancer Inst., 92, 564, 10.1093/jnci/92.7.564
Turner, 2007, BRCA1 Dysfunction in Sporadic Basal-Like Breast Cancer, Oncogene, 26, 2126, 10.1038/sj.onc.1210014
Herman, 1995, Inactivation of the CDKN2/p16/MTS1 Gene Is Frequently Associated with Aberrant DNA Methylation in All Common Human Cancers, Cancer Res., 55, 4525
Esteller, 2001, DNA Methylation Patterns in Hereditary Human Cancers Mimic Sporadic Tumorigenesis, Hum. Mol. Genet., 10, 3001, 10.1093/hmg/10.26.3001
Toyooka, 2001, DNA Methylation Profiles of Lung Tumors, Mol. Cancer Ther., 1, 61
Rosas, 2001, Promoter Hypermethylation Patterns of p16, O6-Methylguanine-DNA-Methyltransferase, and Death-Associated Protein Kinase in Tumors and Saliva of Head and Neck Cancer Patients, Cancer Res., 61, 939
Sanchez-Cespedes, 2000, Gene Promoter Hypermethylation in Tumors and Serum of Head and Neck Cancer Patients, Cancer Res., 60, 892
Herman, 1996, Hypermethylation-Associated Inactivation Indicates a Tumor Suppressor Role for p15INK4B, Cancer Res., 56, 722
Batova, 1997, Frequent and Selective Methylation of p15 and Deletion of Both p15 and p16 in T-Cell Acute Lymphoblastic Leukemia, Cancer Res., 57, 832
Graff, 1995, E-Cadherin Expression Is Silenced by DNA hypermethylation in Human Breast and Prostate Carcinomas, Cancer Res., 55, 5195
Graff, 1998, Distinct Patterns of E-Cadherin CpG Island Methylation in Papillary, Follicular, Hurthle’s Cell, and Poorly Differentiated Human Thyroid Carcinoma, Cancer Res., 58, 2063
Lapidus, 1996, Methylation of Estrogen and Progesterone Receptor Gene 5′ CpG Islands Correlates with Lack of Estrogen and Progesterone Receptor Gene Expression in Breast Tumors, Clin. Cancer Res., 2, 805
Ottaviano, 1994, Methylation of the Estrogen Receptor Gene CpG Island Marks Loss of Estrogen Receptor Expression in Human Breast Cancer Cells, Cancer Res., 54, 2552
Issa, 1996, Methylation of the Estrogen Receptor CpG Island in Lung Tumors Is Related to the Specific Type of Carcinogen Exposure, Cancer Res., 56, 3655
Issa, 1996, The Estrogen Receptor CpG Island Is Methylated in Most Hematopoietic Neoplasms, Cancer Res., 56, 973
Yan, 2001, Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer, J. Mammary Gland Biol. Neoplasia, 6, 10.1023/A:1011308707512
Li, 2000, Frequent Methylation of Estrogen Receptor in Prostate Cancer: Correlation with Tumor Progression, Cancer Res., 60, 702
Samowitz, 2005, Evaluation of a Large, Population-Based Sample Supports a CpG Island Methylator Phenotype in Colon Cancer, Gastroenterology, 129, 837, 10.1053/j.gastro.2005.06.020
Watanabe, 2007, A Change in Promoter Methylation of hMLH1 Is a Cause of Acquired Resistance to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer, Anticancer Res., 27, 1449
Herman, 1998, Incidence and Functional Consequences of hMLH1 Promoter Hypermethylation in Colorectal Carcinoma, Proc. Natl. Acad. Sci. U. S. A., 95, 6870, 10.1073/pnas.95.12.6870
Kane, 1997, Methylation of the hMLH1 Promoter Correlates with Lack of Expression of hMLH1 in Sporadic Colon Tumors and Mismatch Repair-Defective Human Tumor Cell Lines, Cancer Res., 57, 808
Esteller, 1998, MLH1 Promoter Hypermethylation Is Associated with the Microsatellite Instability Phenotype in Sporadic Endometrial Carcinomas, Oncogene, 17, 2413, 10.1038/sj.onc.1202178
Leung, 1999, hMLH1 Promoter Methylation and Lack of hMLH1 Expression in Sporadic Gastric Carcinomas with High-Frequency Microsatellite Instability, Cancer Res., 59, 159
Agathanggelou, 2001, Methylation Associated Inactivation of RASSF1A from Region 3p21.3 in Lung, Breast and Ovarian Tumours, Oncogene, 20, 1509, 10.1038/sj.onc.1204175
Choi, 2006, Aberrant Hypermethylation of RASSF1A Promoter in Ovarian Borderline Tumors and Carcinomas, Virchows Arch, 448, 331, 10.1007/s00428-005-0091-3
Greger, 1994, Frequency and Parental Origin of Hypermethylated RB1 Alleles in Retinoblastoma, Hum. Genet., 94, 491, 10.1007/BF00211013
Stirzaker, 1997, Extensive DNA Methylation Spanning the Rb Promoter in Retinoblastoma Tumors, Cancer Res., 57, 2229
Gonzalez-Gomez, 2003, CpG Island Methylation Status and Mutation Analysis of the RB1 Gene Essential Promoter Region and Protein-Binding Pocket Domain in Nervous System Tumours, Br. J. Cancer, 88, 109, 10.1038/sj.bjc.6600737
Herman, 1994, Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma, Proc. Natl. Acad. Sci. U. S. A., 91, 9700, 10.1073/pnas.91.21.9700
Clifford, 1998, Inactivation of the von Hippel-Lindau (VHL) Tumour Suppressor Gene and Allelic Losses at Chromosome Arm 3p in Primary Renal Cell Carcinoma: Evidence for a VHL-Independent Pathway in Clear Cell Renal Tumourigenesis, Genes Chromosomes Cancer, 22, 200, 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#
Kurkjian, 2008, DNA Methylation: Its Role in Cancer Development and Therapy, Curr. Probl. Cancer, 32, 187, 10.1016/j.currproblcancer.2008.08.002
Eads, 2002, Complete Genetic Suppression of Polyp Formation and Reduction of CpG-Island Hypermethylation in Apc(Min/+) Dnmt1-Hypomorphic Mice, Cancer Res., 62, 1296
Lin, 2006, Suppression of Intestinal Neoplasia by Deletion of Dnmt3b, Mol. Cell Biol., 26, 2976, 10.1128/MCB.26.8.2976-2983.2006
Linhart, 2007, Dnmt3b Promotes Tumorigenesis In Vivo by Gene-Specific De Novo Methylation and Transcriptional Silencing, Genes Dev., 21, 3110, 10.1101/gad.1594007
Fabbri, 2010, Epigenetics and miRNAs in Human Cancer, Adv. Genet., 70, 87, 10.1016/B978-0-12-380866-0.60004-6
Roman-Gomez, 2009, Epigenetic Regulation of microRNAs in Acute Lymphoblastic Leukemia, J. Clin. Oncol., 27, 1316, 10.1200/JCO.2008.19.3441
Agirre, 2009, Epigenetic Silencing of the Tumor Suppressor microRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia, Cancer Res., 69, 4443, 10.1158/0008-5472.CAN-08-4025
Yi, 2008, Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors, Cancer Res., 68, 8094, 10.1158/0008-5472.CAN-07-6208
Saito, 2002, Overexpression of a Splice Variant of DNA Methyltransferase 3b, DNMT3b4, Associated with DNA Hypomethylation on Pericentromeric Satellite Regions during Human Hepatocarcinogenesis, Proc. Natl. Acad. Sci. U. S. A., 99, 10060, 10.1073/pnas.152121799
Wang, 2006, Expression of Delta DNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non-Small Cell Lung Cancer, Cancer Res., 66, 8361, 10.1158/0008-5472.CAN-06-2031
Wang, 2006, A Novel DNMT3B Subfamily, DeltaDNMT3B, Is the Predominant Form of DNMT3B in Non-Small Cell Lung Cancer, Int. J. Oncol., 29, 201
Ostler, 2007, Cancer Cells Express Aberrant DNMT3B Transcripts Encoding Truncated Proteins, Oncogene, 26, 5553, 10.1038/sj.onc.1210351
Eden, 2003, Chromosomal Instability and Tumors Promoted by DNA Hypomethylation, Science, 300, 455, 10.1126/science.1083557
Gaudet, 2003, Induction of Tumors in Mice by Genomic Hypomethylation, Science, 300, 489, 10.1126/science.1083558
Dodge, 2005, Inactivation of Dnmt3b in Mouse Embryonic Fibroblasts Results in DNA Hypomethylation, Chromosomal Instability, and Spontaneous Immortalization, J. Biol. Chem., 280, 17986, 10.1074/jbc.M413246200
Brown, 2007, DNMT1 Knockout Delivers a Strong Blow to Genome Stability and Cell Viability, Nat. Genet., 39, 289, 10.1038/ng0307-289
Haas, 2006, Treatment of Myelodysplastic Syndrome with a DNA Methyltransferase Inhibitor: Lack of Evidence for Induction of Chromosomal Instability, Leuk. Res., 30, 338, 10.1016/j.leukres.2005.07.014
Liang, 2002, Analysis of Gene Induction in Human Fibroblasts and Bladder Cancer Cells Exposed to the Methylation Inhibitor 5-aza-2′-deoxycytidine, Cancer Res., 62, 961
Yoo, 2006, Epigenetic Therapy of Cancer: Past, Present and Future, Nat. Rev. Drug Discov., 5, 37, 10.1038/nrd1930
Jones, 1980, Cellular Differentiation, Cytidine Analogs and DNA Methylation, Cell, 20, 85, 10.1016/0092-8674(80)90237-8
Santi, 1984, Covalent Bond Formation between a DNA-Cytosine Methyltransferase and DNA Containing 5-Azacytosine, Proc. Natl. Acad. Sci. U. S. A., 81, 6993, 10.1073/pnas.81.22.6993
Ghoshal, 2005, 5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal, Mol. Cell Biol., 25, 4727, 10.1128/MCB.25.11.4727-4741.2005
Qin, 2007, Effect of Cytarabine and Decitabine in Combination in Human Leukemic Cell Lines, Clin. Cancer Res., 13, 4225, 10.1158/1078-0432.CCR-06-2762
Hollenbach, 2010, A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines, PLoS One, 5, e9001, 10.1371/journal.pone.0009001
Stresemann, 2008, Modes of Action of the DNA Methyltransferase Inhibitors Azacytidine and Decitabine, Int. J. Cancer, 123, 8, 10.1002/ijc.23607
Velez-Garcia, 1977, Twice Weekly 5-Azacytidine Infusion in Dissmeinated Metastatic Cancer: A Phase II Study, Cancer Treat. Rep., 61, 1675
Srinivasan, 1982, Phase II Study of 5-Azacytidine in Sarcomas of Bone, Am. J. Clin. Oncol., 5, 411, 10.1097/00000421-198208000-00011
Momparler, 1985, Clinical Trial on 5-Aza-2′-Deoxycytidine in Patients with Acute Leukemia, Pharmacol. Ther., 30, 277, 10.1016/0163-7258(85)90052-X
Silverman, 2002, Randomized Controlled Trial of Azacitidine in Patients with the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B, J. Clin. Oncol., 20, 2429, 10.1200/JCO.2002.04.117
Kornblith, 2002, Impact of Azacytidine on the Quality of Life of Patients with Myelodysplastic Syndrome Treated in a Randomized Phase III Trial: A Cancer and Leukemia Group B Study, J. Clin. Oncol., 20, 2441, 10.1200/JCO.2002.04.044
Silverman, 2006, Further Analysis of Trials with Azacitidine in Patients with Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B, J. Clin. Oncol., 24, 3895, 10.1200/JCO.2005.05.4346
Fenaux, 2009, Efficacy of Azacitidine Compared with That of Conventional Care Regimens in the Treatment of Higher-Risk Myelodysplastic Syndromes: A Randomised, Open-Label, Phase III Study, Lancet Oncol., 10, 223, 10.1016/S1470-2045(09)70003-8
Kantarjian, 2006, Decitabine Improves Patient Outcomes in Myelodysplastic Syndromes: Results of a Phase III Randomized Study, Cancer, 106, 1794, 10.1002/cncr.21792
Issa, 2004, Phase 1 Study of Low-Dose Prolonged Exposure Schedules of the Hypomethylating Agent 5-Aza-2′-Deoxycytidine (Decitabine) in Hematopoietic Malignancies, Blood, 103, 1635, 10.1182/blood-2003-03-0687
Kantarjian, 2007, Results of a Randomized Study of 3 Schedules of Low-Dose Decitabine in Higher-Risk Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia, Blood, 109, 52, 10.1182/blood-2006-05-021162
Steensma, 2009, Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial, J. Clin. Oncol., 27, 3842, 10.1200/JCO.2008.19.6550
Cashen, 2010, Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients with Acute Myeloid Leukemia, J. Clin. Oncol., 28, 556, 10.1200/JCO.2009.23.9178
Shen, 2010, DNA Methylation Predicts Survival and Response to Therapy in Patients with Myelodysplastic Syndromes, J. Clin. Oncol., 28, 605, 10.1200/JCO.2009.23.4781
Fang, 2010, A Phase 1 and Pharmacodynamic Study of Decitabine in Combination with Carboplatin in Patients with Recurrent, Platinum-Resistant, Epithelial Ovarian Cancer, Cancer, 116, 4043, 10.1002/cncr.25204
http://www.standup2cancer.org/node/4446
Byun, 2008, 2′-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-Azacytidine: A Novel Inhibitor of DNA Methyltransferase That Requires Activation by Human Carboxylesterase 1, Cancer Lett., 266, 238, 10.1016/j.canlet.2008.02.069
Yoo, 2007, Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides, Cancer Res., 67, 6400, 10.1158/0008-5472.CAN-07-0251
Chuang, 2010, S110, a 5-Aza-2′-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In Vivo and Can Reduce Tumor Growth, Mol. Cancer Ther., 9, 1443, 10.1158/1535-7163.MCT-09-1048
Lavelle, 2010, S110, a Novel Decitabine Dinucleotide, Increases Fetal Hemoglobin Levels in Baboons (P. anubis), J. Transl. Med., 8, 92, 10.1186/1479-5876-8-92
Brueckner, 2010, Lyko F: Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy, Mol. Cancer Ther., 9, 1256, 10.1158/1535-7163.MCT-09-1202
McGregor, 1989, TFT and 6TG Resistance of Mouse Lymphoma Cells to Analogs of Azacytidine, Carcinogenesis, 10, 2003, 10.1093/carcin/10.11.2003
Osterman, 1988, 5-Fluorocytosine in DNA Is a Mechanism-Based Inhibitor of HhaI Methylase, Biochemistry, 27, 5204, 10.1021/bi00414a039
Champion, 2010, Mechanistic Insights on the Inhibition of c5 DNA Methyltransferases by Zebularine, PLoS One, 5, e12388, 10.1371/journal.pone.0012388
Newman, 1982, Metabolism and Mechanism of Action of 5-Fluorodeoxycytidine, Proc. Natl. Acad. Sci. U. S. A., 79, 6419, 10.1073/pnas.79.21.6419
Flotho, 2009, The DNA Methyltransferase Inhibitors Azacitidine, Decitabine and Zebularine Exert Differential Effects on Cancer Gene Expression in Acute Myeloid Leukemia Cells, Leukemia, 23, 1019, 10.1038/leu.2008.397
Amato, 2007, Inhibition of DNA Methylation by Antisense Oligonucleotide MG98 as Cancer Therapy, Clin. Genitourin. Cancer, 5, 422, 10.3816/CGC.2007.n.029
Winquist, 2006, Phase II Trial of DNA Methyltransferase 1 Inhibition with the Antisense Oligonucleotide MG98 in Patients with Metastatic Renal Carcinoma: A National Cancer Institute of Canada Clinical Trials Group Investigational New Drug Study, Invest. New Drugs, 24, 159, 10.1007/s10637-006-5938-1
Klisovic, 2008, Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination with High-Dose Cytarabine in Patients with Acute Myeloid Leukemia, Clin. Cancer Res., 14, 3889, 10.1158/1078-0432.CCR-08-0109
Plummer, 2009, Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors, Clin. Cancer Res., 15, 3177, 10.1158/1078-0432.CCR-08-2859
Garzon, 2009, MicroRNA 29b Functions in Acute Myeloid Leukemia, Blood, 114, 5331, 10.1182/blood-2009-03-211938
Qin, 2009, Mechanisms of Resistance to 5-Aza-2′-Deoxycytidine in Human Cancer Cell Lines, Blood, 113, 659, 10.1182/blood-2008-02-140038
Cornacchia, 1988, Hydralazine and Procainamide Inhibit T Cell DNA Methylation and Induce Autoreactivity, J. Immunol., 140, 2197, 10.4049/jimmunol.140.7.2197
Segura-Pacheco, 2003, Reactivation of Tumor Suppressor Genes by the Cardiovascular Drugs Hydralazine and Procainamide and Their Potential Use in Cancer Therapy, Clin. Cancer Res., 9, 1596
Deng, 2003, Hydralazine May Induce Autoimmunity by Inhibiting Extracellular Signal-Regulated Kinase Pathway Signaling, Arthritis Rheum., 48, 746, 10.1002/art.10833
Chuang, 2005, Comparison of Biological Effects of Non-Nucleoside DNA Methylation Inhibitors versus 5-Aza-2′-Deoxycytidine, Mol. Cancer Ther., 4, 1515, 10.1158/1535-7163.MCT-05-0172
Coronel, J., Cetina, L., Pacheco, I., Trejo-Becerril, C., Gonzalez-Fierro, A., de la Cruz-Hernandez, E., Perez-Cardenas, E., Taja-Chayeb, L., Arias-Bofill, D., Candelaria, M., et al. A Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Chemotherapy Plus Epigenetic Therapy with Hydralazine Valproate for Advanced Cervical Cancer: Preliminary Results. Med Oncol 2010 Oct 8. [Epub ahead of print]
Candelaria, 2011, Hydralazine and Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome: Preliminary Results of a Phase-II Trial, Ann. Hematol., 90, 379, 10.1007/s00277-010-1090-2
Villar-Garea, 2003, Procaine Is a DNA-Demethylating Agent with Growth-Inhibitory Effects in Human Cancer Cells, Cancer Res., 63, 4984
Stresemann, 2006, Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines, Cancer Res., 66, 2794, 10.1158/0008-5472.CAN-05-2821
Fang, 2003, Tea Polyphenol (–)-Epigallocatechin-3-Gallate Inhibits DNA Methyltransferase and Reactivates Methylation-Silenced Genes in Cancer Cell Lines, Cancer Res., 63, 7563
Siedlecki, 2006, Discovery of Two Novel, Small-Molecule Inhibitors of DNA Methylation, J. Med. Chem., 49, 678, 10.1021/jm050844z
Brueckner, 2005, Epigenetic Reactivation of Tumor Suppressor Genes by a Novel Small-Molecule Inhibitor of Human DNA Methyltransferases, Cancer Res., 65, 6305, 10.1158/0008-5472.CAN-04-2957
Lin, 2007, Mithramycin A Inhibits DNA Methyltransferase and Metastasis Potential of Lung Cancer Cells, Anticancer Drugs, 18, 1157, 10.1097/CAD.0b013e3282a215e9
Datta, 2009, A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation, Cancer Res., 69, 4277, 10.1158/0008-5472.CAN-08-3669
Kuck, 2010, Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells, Mol. Cancer Ther., 9, 3015, 10.1158/1535-7163.MCT-10-0609
Kuck, 2010, Novel and Selective DNA Methyltransferase Inhibitors: Docking-Based Virtual Screening and Experimental Evaluation, Bioorg. Med. Chem., 18, 822, 10.1016/j.bmc.2009.11.050
Song, 2011, Structure of DNMT1-DNA Complex Reveals a Role for Autoinhibition in Maintenance DNA Methylation, Science, 331, 1036, 10.1126/science.1195380
http://www.ebi.ac.uk/chembldb/index.php
http://www.bindingdb.org
Yang, 2010, Targeting DNA Methylation for Epigenetic Therapy, Trends Pharmacol. Sci., 31, 536, 10.1016/j.tips.2010.08.001
Medina-Franco, 2011, Advances in the Computational Development of DNA Methyltransferase Inhibitors, Drug Discov. Today, 16, 418, 10.1016/j.drudis.2011.02.003
Lin, 2007, Role of Nucleosomal Occupancy in the Epigenetic Silencing of the MLH1 CpG Island, Cancer Cell, 12, 432, 10.1016/j.ccr.2007.10.014
Margueron, 2011, The Polycomb Complex PRC2 and Its Mark in Life, Nature, 469, 343, 10.1038/nature09784
Pradhan, 2009, SET7/9 Mediated Methylation of Non-Histone Proteins in Mammalian Cells, Epigenetics, 4, 383, 10.4161/epi.4.6.9450
Nicholson, 2009, LSD1 Demethylates Histone and Non-Histone Proteins, Epigenetics, 4, 129, 10.4161/epi.4.3.8443
Gollob, 2006, Phase I Trial of Sequential Low-Dose 5-Aza-2′-Deoxycytidine Plus High-Dose Intravenous Bolus Interleukin-2 in Patients with Melanoma or Renal Cell Carcinoma, Clin. Cancer Res., 12, 4619, 10.1158/1078-0432.CCR-06-0883
Soriano, 2007, Safety and Clinical Activity of the Combination of 5-Azacytidine, Valproic Acid, and All-Trans Retinoic Acid in Acute Myeloid Leukemia and Myelodysplastic Syndrome, Blood, 110, 2302, 10.1182/blood-2007-03-078576
Raza, 2008, Combination of 5-Azacytidine and Thalidomide for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia, Cancer, 113, 1596, 10.1002/cncr.23789
Scott, 2010, Prolonged Responses in Patients with MDS and CMML Treated with Azacitidine and Etanercept, Br. J. Haematol., 148, 944, 10.1111/j.1365-2141.2009.08061.x
Borthakur, 2010, Report of a Phase 1/2 Study of a Combination of Azacitidine and Cytarabine in Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndromes, Leuk. Lymphoma, 51, 73, 10.3109/10428190903318329